Gallbladder cancer future or investigational therapies: Difference between revisions
No edit summary |
Mahshid |
||
Line 18: | Line 18: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
[[Category:Hepatology]] |
Latest revision as of 23:30, 26 November 2017
Gallbladder cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gallbladder cancer future or investigational therapies On the Web |
American Roentgen Ray Society Images of Gallbladder cancer future or investigational therapies |
FDA on Gallbladder cancer future or investigational therapies |
CDC on Gallbladder cancer future or investigational therapies |
Gallbladder cancer future or investigational therapies in the news |
Blogs on Gallbladder cancer future or investigational therapies |
Risk calculators and risk factors for Gallbladder cancer future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Future or Investigational Therapies
Clinical trials are exploring ways of improving local control with radiation therapy combined with radiosensitizer drugs. When possible, such patients are appropriately considered candidates for these studies.